Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Efficacy and safety of biphasic insulin aspart 70/30 versus exenatide in subjects with type 2 diabetes failing to achieve glycemic control with metformin and a sulfonylurea.

Bergenstal R, Lewin A, Bailey T, Chang D, Gylvin T, Roberts V; NovoLog Mix-vs.-Exenatide Study Group.

Curr Med Res Opin. 2009 Jan;25(1):65-75. doi: 10.1185/03007990802597951 .

PMID:
19210140
2.

Growth hormone (GH) secretion during continuous infusion of GH-releasing peptide: partial response attenuation.

DeBell WK, Pezzoli SS, Thorner MO.

J Clin Endocrinol Metab. 1991 Jun;72(6):1312-6.

PMID:
2026752

Supplemental Content

Loading ...
Write to the Help Desk